Image

The OVAL Study: A Randomized, Controlled, Double-Arm,Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs. Paclitaxel Combined with Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer

Study on Investigational Medication with Chemotherapy for Ovarian Cancer

Recruiting
18 years and older
Female
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the effects of an investigational medication combined with a standard chemotherapy drug called paclitaxel in patients with ovarian cancer. Ovarian cancer is a disease where cancer cells form in the tissues of the ovary. The study aims to compare the investigational medication and paclitaxel with a combination of paclitaxel and a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medication.

Participants in the study will receive either the investigational medication with paclitaxel or paclitaxel with a placebo. The study will monitor the safety and effectiveness of these treatments in managing ovarian cancer, focusing on patients whose disease does not respond to platinum-based chemotherapy.

  • Who can participate: Participants must have epithelial ovarian cancer confirmed by histology and have platinum-resistant disease.
  • Study details: Participants will receive treatment with either the investigational medication and paclitaxel or paclitaxel with a placebo.
Print
Study details
    Ovarian Cancer

TX10241

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.